BioSpace News Archive

Press Releases

Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma

April 13, 2026
·
7 min read
Press Releases

Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients

April 13, 2026
·
7 min read
Press Releases

Eclipse Life Sciences Completes Enrollment in Phase 2 Study Evaluating EC-104 for Diabetic Macular Edema (DME)

April 13, 2026
·
3 min read
Press Releases

ImageneBio Announces $30 Million Private Placement

April 13, 2026
·
5 min read
Press Releases

Soleo Health Opens New Ambulatory Infusion Center in Louisville, Kentucky

April 13, 2026
·
2 min read
Press Releases

Lilly’s Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a venetoclax time-limited regimen in patients with previously treated CLL/SLL

April 13, 2026
·
16 min read
Press Releases

Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026

April 13, 2026
·
6 min read
Press Releases

Leukogene Therapeutics Announces Two Presentations at the AACR Annual Meeting 2026 Highlighting MHC Class II-Engager Immunotherapies

April 13, 2026
·
2 min read
Press Releases

Viatris to Report First Quarter 2026 Financial Results on May 7, 2026

April 13, 2026
·
1 min read
Press Releases

Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy

April 13, 2026
·
13 min read